PetVivo Holdings, Inc. and PiezoBioMembrane Inc. announced a Master Services Agreement to jointly develop innovative functional biomaterials. This strategic partnership aims to combine PetVivo’s extracellular matrix (ECM) biomaterial with PiezoBio’s biodegradable piezoelectric nanofibers.
The anticipated piezo-biomaterial derived from this collaboration is intended to have functional attributes that can be biologically activated to promote regeneration and/or remodeling of damaged or injured tissue and bone in both animals and humans. This represents a significant advancement in regenerative medicine.
This collaboration opens a potential pathway into the human osteoarthritis market, which is estimated at $11.2 billion in the U.S. and $33 billion globally for joint replacements. The partnership leverages PetVivo's biomaterial expertise and PiezoBio's piezoelectric material knowledge to create next-generation therapeutic solutions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.